lobbying_activities: 3143395
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3143395 | 64a0bbc3-1f8a-4922-9a46-fcecfd7257dc | Q1 | FORBES-TATE | 400976792 | CSL BEHRING | 2024 | first_quarter | MED | Issues related to Rx pricing; Issues related to plasma and plasma derived therapies; Issues related to H.R. - 6465 Preserving Life-saving Access to Specialty Medicines in America Act. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2024-04-12T21:10:20-04:00 |